Tumour necrosis factor (TNF) is a cytokine with multiple biological ac
tivities which plays a pivotal role in the response of the body to inf
ection. TNF is secreted in the the monomeric form and associates to yi
eld a biologically active oligomeric molecule. Bioactive TNF can be me
asured in plasma using cytotoxic assays which employ the murine cell-l
ines L929 or WEHI 164 clone 13. However, it has become clear that inac
tive TNF also circulates in vivo, which is not detected by bioassay. T
hese inactive forms may play an important role in the regulation of TN
F activity. The rat is often used as a model for the study of acute in
fection and its systemic effects. Our aim was to develop an ELISA for
rat TNF which would provide a convenient and cost effective method of
assay. The assay employs two commercially available antibodies raised
against recombinant murine TNF (rMuTNF) which exhibit cross-reactivity
with rat TNF. The lower limit of detection for this assay was determi
ned to be 39.0 pg/ml rMuTNF. The inter and intra-assay coefficients of
variation were < 12.0%. Specificity of the assay was shown by the hig
h degree of parallelism obtained between rMuTNF and commercially avail
able rRatTNF. The assay described measures rat TNF in both plasma and
tissue culture supernatant. The measurement of plasma concentrations o
f TNF using both the ELISA and bioassay may help elucidate more fully
the biological importance of TNF.